v3.26.1
Investment in receivables, net (Tables) - Investments in receivables, net
6 Months Ended
Jun. 30, 2026
Investment in receivables, net  
Schedule of roll forward of the balance of the investment in receivables, net and negative allowance for expected recoveries

The following table presents the roll forward of the balance of the investment in receivables, net for the following periods (in thousands):

For the Three Months Ended

For the Six Months Ended

June 30, 

June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Balance, beginning of period

$

1,929,069

$

1,561,595

$

1,928,742

$

1,497,748

Purchases

152,242

125,278

301,947

300,501

Cash collections

(300,856)

(255,739)

(610,754)

(516,629)

Total portfolio income

156,253

138,877

313,859

277,571

Changes in expected current period recoveries

3,544

4,178

14,275

10,575

Changes in expected future period recoveries

5,467

(2,622)

1,792

(5,399)

Foreign currency adjustments

1,100

18,234

(3,042)

25,434

Balance, end of period

$

1,946,819

$

1,589,801

$

1,946,819

$

1,589,801

The table below provides the detail on the establishment of negative allowance for expected recoveries of portfolios purchased during the periods presented (in thousands):

For the Three Months Ended

For the Six Months Ended

June 30, 

June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Purchase price

$

152,242

$

125,278

$

301,947

$

300,501

Allowance for credit losses

2,589,339

1,518,687

5,006,767

3,952,988

Amortized cost

2,741,581

1,643,965

5,308,714

4,253,489

Noncredit discount

131,582

115,643

272,620

263,495

Face value

2,873,163

1,759,609

5,581,334

4,516,984

Write-off of amortized cost

(2,741,581)

(1,643,965)

(5,308,714)

(4,253,489)

Write-off of noncredit discount

(131,582)

(115,643)

(272,620)

(263,495)

Negative allowance

152,242

125,278

301,947

300,501

Negative allowance for expected recoveries

$

152,242

$

125,278

$

301,947

$

300,501

Schedule of information on the past due and non-accrual buckets for the assets acquired in the Conn's portfolio purchase The table below presents the information on the past due and non-accrual buckets for the assets acquired in the performing portfolio purchases, and does not include all other purchased loans as they were charged-off at the time of purchase, (in thousands):

As of June 30, 

As of December 31, 

Delinquency vintage

  ​ ​ ​

2026

  ​ ​ ​

2025

United States

Current

$

195,168

$

326,381

30-59

19,523

49,467

60-89

13,985

39,402

>90

72,397

109,562

Total

$

301,073

$

524,812

Schedule of non-accrual performing loans by segment

The following table presents non-accrual performing loans by segment (in thousands).

As of June 30, 

As of December 31, 

2026

2025

Nonaccrual

Nonaccrual

with No

with No

  ​ ​ ​

Nonaccrual

  ​ ​ ​

Allowance

  ​ ​ ​

Nonaccrual

  ​ ​ ​

Allowance

United States

72,397

109,562

Total

$

72,397

$

$

109,562

$